Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2008
06/11/2008CN101194890A Oral cavity rapid disintegrating tablet medicament and method of preparing the same
06/11/2008CN101194888A Drotaverin HCl freeze-dried powder needle injection and method for producing the same
06/11/2008CN101194726A Movement nutrition food
06/11/2008CN101194616A Preparation of avermectin medicament sustained-release nano microsphere preparations and uses thereof
06/11/2008CN100393731C Water soluble phosphate ester salt ofú¿Zú®-3'-hydroxy-3,4',5-trimethoxydiphenyl ethylene, and its preparation method ,pharmaceutical composition and uses
06/11/2008CN100393724C 20-esterifiable camptothecine derivative and method for making same and pharmaceutical combination and uses
06/11/2008CN100393722C Inhibitors of nucleoside metabolism
06/11/2008CN100393721C N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
06/11/2008CN100393720C Cyclic benzimidazoles
06/11/2008CN100393719C Process for preparing an anticholinergic
06/11/2008CN100393718C Thiazole derivatives as npy antagonists
06/11/2008CN100393716C Coumarin derivatives, and their preparing method and use as alpha, receptor agonist
06/11/2008CN100393715C Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase
06/11/2008CN100393713C Therapeutic agents useful for treating pain
06/11/2008CN100393706C Substituted dihydrochinazolines having antiviral properties
06/11/2008CN100393704C Novel alkali B of cohosh root and its uses in preparing anti-myocardial ischemia drug
06/11/2008CN100393703C 1,2,3,4-tetrahydroisoquinoline derivatives
06/11/2008CN100393360C Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
06/11/2008CN100393359C Multi-element composition for eliminating pylorus spiro-bacillus
06/11/2008CN100393356C Modified cytokines for use in cancer therapy
06/11/2008CN100393349C Analgetic and its use
06/11/2008CN100393341C Hyperosteogeny-treating ointment
06/11/2008CN100393337C Synergistic medicinal composition
06/11/2008CN100393325C Medicine for treating Youth acne varioliformis and preparing method thereof
06/11/2008CN100393322C Separate type medical material
06/11/2008CN100393321C Oral antilipemic liquid and its preparing method
06/11/2008CN100393320C Oligonucleotide medicine for treating myophagism
06/11/2008CN100393319C Astragaloside cyclodextrin clathrate, its preparation and preparing mehtod
06/11/2008CN100393318C Asiaticoside external use sterile powder and its preparation method
06/11/2008CN100393317C Polyene phosphatidyl choline infusion solution and its preparing method
06/11/2008CN100393316C Suppository containing prazosin hydrochloride, its preparation method and application
06/11/2008CN100393315C Novel nimodipine composition
06/11/2008CN100393314C Combination of Liranaftate gelatin and preparation method
06/11/2008CN100393313C Bilobalide B powder injection and its preparing method
06/11/2008CN100393312C Soft capsule of mycophenolic acid or like and its preparing method
06/11/2008CN100393311C Trimebutine maleate dispersion tablet
06/11/2008CN100393310C Frozen powder injection of tiopronin
06/11/2008CN100393309C Use of alpha-phenylthiocarboxylic and alpha-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
06/11/2008CN100393308C Use of Coleus forskohlii extract agent in tumor growth and preliferation inhibiting agent
06/11/2008CN100393305C Montelukast oral disintegrating tablet formulation and its preparing method
06/11/2008CN100393304C Fine granules containing acid-labile medicine and preparation thereof
06/11/2008CN100393303C Vitamin A liposome artificial lacrimal eye drops
06/11/2008CN100393246C Infant formula supplemented with phospholipids
06/11/2008CN100393243C Nutritional compositions
06/10/2008US7385088 Compounds from Antrodia camphorata
06/10/2008US7385084 Compounds are significantly cytotoxic, show unexpectedly high water solubility and bioavailability and are effective when used in combination with other anticancer drugs like paclitaxel or its analogs;Lithium; 2-(N'-methyl-N'-thiobenzoyl-hydrazinocarbonyl)-1-(methyl-thiobenzoyl-hydrazono)-ethanolate
06/10/2008US7385083 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity
06/10/2008US7385063 Method for preparing imidazole derivatives
06/10/2008US7385061 Furazanobenzimidazoles
06/10/2008US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product
06/10/2008US7385042 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain)
06/10/2008US7385039 Methods and compositions for regulating imidazoline receptors
06/10/2008US7384983 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders
06/10/2008US7384982 e.g., disodium N-(5-chlorosalicyloyl)-8-amN-(10-[2-hydroxybenzoyl]amino)decanoate and disodium N-(10-[2-hydroxybenzoyl]amino)decanoate
06/10/2008US7384981 Preparation for improving the action of receptors
06/10/2008US7384980 Derivatives of 3,3-diphenylpropylamines
06/10/2008US7384979 Substituted amino acids as erythropoietin mimetics
06/10/2008US7384978 Compounds and methods for delivery of prostacyclin analogs
06/10/2008US7384977 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases
06/10/2008US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use
06/10/2008US7384975 Substituted furochromenes, preparation thereof and their antiinflammatory action
06/10/2008US7384974 effective in reducing triglyceride levels in the liver and reducing blood glucose levels
06/10/2008US7384973 Materials and methods for treating hypercholesterolemia
06/10/2008US7384972 administering a dietary indole, particularly Diindolylmethane (DIM), as well as its precursor, Indole-3-carbinol (I3C), and cogener, 2-(Indol-3-ylmethyl)-3,3'diindolylmethane (LTR-1), to reduce or prevent pain
06/10/2008US7384971 Phytochemicals for the treatment of cervical dysplasia
06/10/2008US7384970 Inhibitors of cathepsin S
06/10/2008US7384969 N-(1H-indolyl)-1H-indole-2-carboxamide derivatives, their preparation and their therapeutic use
06/10/2008US7384968 Thiazole-amine compounds for the treatment of neurodegenerative disorders
06/10/2008US7384967 Aryl carbonyl derivatives as therapeutic agents
06/10/2008US7384966 Anticancer, antiproliferative, antitumor agents; particularly active against breast cancer cell; compounds can be use in Positron Emission Tomography imaging; 2-(3,4-Dimethoxyphenyl)benzothiazole N-oxide
06/10/2008US7384965 Fused heterocyclic derivatives as PPAR modulators
06/10/2008US7384964 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
06/10/2008US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase
06/10/2008US7384962 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
06/10/2008US7384961 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants
06/10/2008US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders
06/10/2008US7384959 Treatment of convulsive states
06/10/2008US7384958 Quinoline inhibitors of cGMP phosphodiesterase
06/10/2008US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives
06/10/2008US7384955 N-[1-(cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-2,2-dimethyl-propanamide; cannabinoid CB1/CB2 receptor agonists; analgesic; in therapy, in particular in the management of pain
06/10/2008US7384954 3-Imidazol-1-yl-1-azabicyclo[2.2.2]octane; agonist, partial agonist, or antagonist of the alpha 7 nicotinic acetylcholine receptor; antidepressant, anxiolytic agent, cognition activator, neuroprotectant; radiolabel
06/10/2008US7384953 Purification of rapamycin
06/10/2008US7384952 1-(3-ethoxybenzyl)-4-[4-[4-[2-(dimethylamino)ethoxy]benzoyl]piperazin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine; small conductance potassium channel (SK channel) blocking activity; gastrointestinal disorders
06/10/2008US7384951 Immunosuppressants; respiratory system disorders; asthma; chronic obstructive pulmonary disease
06/10/2008US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
06/10/2008US7384949 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain
06/10/2008US7384948 Graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
06/10/2008US7384947 Treating cancer with anticarcinogenic agents 3-Amino-9-chloro-5,6,7,8-tetrahydro-naphtho[2,3-b]furan-2-yl))-(2-methyl-pyridin-3-yl)-methanone; antiproliferative agents
06/10/2008US7384946 M3 muscarinic acetylcholine receptor antagonists
06/10/2008US7384945 Indole or benzimidazole derivatives as CB1 inverse agonists
06/10/2008US7384944 Organ grafting; antiarthritic agents; inflammatory bowel disease
06/10/2008US7384943 Substituted chroman derivatives
06/10/2008US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3
06/10/2008US7384941 2-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
06/10/2008US7384940 Calibration kinase resistance; anticancer agents
06/10/2008US7384939 N-(3,5-bis-trifluoromethyl-benzyl)-N-methyl-6-morpholin-4yl-4-o-tolyl-nicotinamide; inhibit interaction of substance P and neurokinin NK-1 receptor site; antiinflammatory; cyclization of amidoethyl-pyridinium salt with cyanoaryl-acrylate followed by amination, hydrogenation, hydrolysis; good yield
06/10/2008US7384938 Aqueous formulations of parasiticides for skin applications
06/10/2008US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders
06/10/2008US7384936 Carboxamidine derivatives and their use in the treatment of vascular diseases
06/10/2008US7384935 Phosphate prodrugs of a farnesyl dibenzodiazepinone, processes for their production and their use as pharmaceuticals